In his pursuit of advancing pharmaceutical research, Ahlam Hosny Mahmoud has engaged in a variety of in vivo experiments involving experimental animals. These experiments are designed with the overarching goal of developing new drugs or identifying new drug indications. One facet of his research involves conducting in vivo experiments on gastric ulcer and inflammatory diseases of soft tissue. In these studies, he meticulously induces diseases in experimental animals and evaluates the efficacy of treatments, with a specific focus on assessing the degree of inflammation using a planimeter.

Furthermore, Ahlam is actively involved in in vivo treatments targeting breast cancer. His efforts contribute to the ongoing exploration of novel approaches for combating this prevalent and challenging disease. Additionally, he undertakes experiments aimed at measuring the toxicity of different compounds, providing crucial insights into the safety profile of potential therapeutic agents. Beyond that, Ahlam investigates the distribution and concentration of trace elements in various organs, shedding light on their potential roles in physiological processes and offering valuable information for drug development. Through these diverse in vivo experiments, he remains dedicated to advancing the frontiers of pharmaceutical and therapeutic research.